August 2022 A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology

Chris Cargill appointed as President and Chief Executive Officer • Dr.

Dimerization: Unveiling Its Role in Receptor Function and Signaling Sonja Peter , Brian Bender , Chris from ARPA-H’s Sprint for Women’s Health Nxera Pharma Wins Biotech Company of the Year and Financing Deal

GPCR Podcast << Back to podcast list Chris Langmead Chris Langmead is Professor, Deputy Director, and Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience

Chris Evans at UCLA.

This means that an Affiliate can receive a commission for a qualifying sale if the deal was created.